| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 03/14/2002 | CA2421187A1 Family member of inhibitor of apoptosis proteins |
| 03/14/2002 | CA2421183A1 Novel polypeptide and anti-hiv agent containing the same |
| 03/14/2002 | CA2421174A1 Cloned cells, embryos, and avians and methods, of producing them |
| 03/14/2002 | CA2421155A1 Osteoclast-associated receptor |
| 03/14/2002 | CA2421075A1 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
| 03/14/2002 | CA2421041A1 Caveolin peptides and their use as therapeutics |
| 03/14/2002 | CA2421027A1 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
| 03/14/2002 | CA2420225A1 Hla-a2.1 binding peptides and their uses |
| 03/14/2002 | CA2419979A1 Mammalian genes; related reagents and methods |
| 03/14/2002 | CA2419943A1 Secretory molecules |
| 03/14/2002 | CA2417660A1 Vp22 protein/nucleic acid aggregates, uses thereof |
| 03/14/2002 | CA2417243A1 Genes encoding polypeptides from methylomonas sp. involved exopolysaccharide production |
| 03/14/2002 | CA2412298A1 Extended native chemical ligation |
| 03/14/2002 | CA2412279A1 "pseudo"-native chemical ligation |
| 03/14/2002 | CA2412278A1 Polymer-modified synthetic proteins |
| 03/14/2002 | CA2412277A1 Synthetic erythropoiesis stimulating proteins |
| 03/14/2002 | CA2389739A1 Mimetic peptides for epitope of apolipoprotein b-100, concatemer and modified peptides thereof, and the vaccine composition comprising the same |
| 03/13/2002 | EP1186890A1 Srsv detection kit |
| 03/13/2002 | EP1186672A2 Polymorphisms in the human organic anion transporter C (OATP-C) gene |
| 03/13/2002 | EP1186665A1 A delivery method for the tumor specific apoptosis inducing activity of apoptin |
| 03/13/2002 | EP1186663A1 Production of pluripotent granulocyte colony-stimulating factor |
| 03/13/2002 | EP1186662A2 Prion binding proteins and uses thereof |
| 03/13/2002 | EP1186661A1 Identification of the major capacitative calcium channel in antigen presenting cells and uses thereof |
| 03/13/2002 | EP1186660A2 Method for obtaining DNA, RNA, peptides, polypeptides or proteins by means of a DNA-recombination technique |
| 03/13/2002 | EP1186655A1 Packaging cell |
| 03/13/2002 | EP1186615A1 Novel protein and dna thereof |
| 03/13/2002 | EP1186614A2 Crystal structure of the 30S ribosome bound to antibiotics |
| 03/13/2002 | EP1186319A1 Use of serum response factor (SRF) modulator for treating SRF related diseases |
| 03/13/2002 | EP1186301A2 Monoclonal antibodies that recognize flk-2 receptors and the isolation of primitive hematopoietic stem cell populations |
| 03/13/2002 | EP1185862A2 Method and compositions relating to insulin resistance disorders |
| 03/13/2002 | EP1185708A1 Means for identifying a novel class of genes resistant to the rice yellow mottle virus and the locus of a major gene of resistance to the virus, and their applications |
| 03/13/2002 | EP1185707A1 Means for identifying the locus of a major resistance gene with respect to the virus of the rice yellow mottle virus and uses thereof |
| 03/13/2002 | EP1185700A1 49 human secreted proteins |
| 03/13/2002 | EP1185696A1 Antisense oligonucleotide modulation of human protein kinase c-delta expression |
| 03/13/2002 | EP1185694A1 49 human secreted proteins |
| 03/13/2002 | EP1185691A1 Neisseria genomic sequences and methods of their use |
| 03/13/2002 | EP1185682A1 Carotenoid ketolase genes and gene products, production of ketocarotenoids and methods of modifying carotenoids using the genes |
| 03/13/2002 | EP1185679A2 Sunflower anti-pathogenic proteins and genes and their uses |
| 03/13/2002 | EP1185678A2 R1 protein from wheat and the use thereof for the production of modified strach |
| 03/13/2002 | EP1185676A2 Rad51 from maize and use thereof |
| 03/13/2002 | EP1185675A1 Escherichia coli strain secreting human granulocyte colony stimulating factor (g-csf) |
| 03/13/2002 | EP1185665A1 INFECTIOUS cDNA CLONE OF GB VIRUS B AND USES THEREOF |
| 03/13/2002 | EP1185664A2 CLONED GENONE OF INFECTIOUS HEPATITIS C VIRUS OF GENOTYPE 2a AND USES THEREOF |
| 03/13/2002 | EP1185663A1 Novel gbv sequence |
| 03/13/2002 | EP1185662A2 Dna vaccines for pets and sport animals |
| 03/13/2002 | EP1185661A2 Bacteriophage rm 378 of a thermophilic host organism |
| 03/13/2002 | EP1185660A2 Porcine circovirus vaccine in recombinant poxvirus |
| 03/13/2002 | EP1185659A2 Dna pcv vaccine |
| 03/13/2002 | EP1185658A2 Novel compounds from moraxella catarrhalis |
| 03/13/2002 | EP1185657A2 Gene involved in epigenetic gene silencing |
| 03/13/2002 | EP1185656A1 Use of the bnm3 transcriptional activator to control plant embryogenesis and regeneration processes |
| 03/13/2002 | EP1185655A1 Equine granulocyte-macrophage colony-stimulating factor (gm-csf) |
| 03/13/2002 | EP1185654A2 Scorpion toxins from buthotus judaicus |
| 03/13/2002 | EP1185653A2 Scorpion toxins from buthotus judaicus |
| 03/13/2002 | EP1185652A2 Nucleic acid encoding proteins involved in protein degradation, products and methods related thereto |
| 03/13/2002 | EP1185651A2 Test animal for atherosclerosis model and methods for testing and screening |
| 03/13/2002 | EP1185650A1 Head trauma induced cytoplasmatic calcium binding protein |
| 03/13/2002 | EP1185649A2 The myostatin gene promoter and inhibition of activation thereof |
| 03/13/2002 | EP1185648A2 Methods and compositions for inhibiting neoplastic cell growth |
| 03/13/2002 | EP1185647A1 Not1 splice variant |
| 03/13/2002 | EP1185646A1 Recombinant nematode nicotinic receptor and uses |
| 03/13/2002 | EP1185645A1 Adipocyte complement related protein homolog zacrp7 |
| 03/13/2002 | EP1185644A1 Assays for caspase activity using green fluorescent proteins |
| 03/13/2002 | EP1185643A1 Adipocyte complement related protein homolog zacrp5 |
| 03/13/2002 | EP1185642A2 Compositions and methods for the treatment of tumor |
| 03/13/2002 | EP1185641A1 Cytokine receptor mouse zcytor10 |
| 03/13/2002 | EP1185640A1 Lipocalin family protein |
| 03/13/2002 | EP1185639A1 Prostate-specific gene, pcgem1, and methods of using pcgem1 to detect, treat, and prevent prostate cancer |
| 03/13/2002 | EP1185638A1 Gene and protein sequences of phage t4 gene 35 |
| 03/13/2002 | EP1185635A2 Non-human transgenic animals deficient in gas6 function and their use |
| 03/13/2002 | EP1185628A2 Isolation of a human retrovirus |
| 03/13/2002 | EP1185624A1 Process of expressing and isolating recombinant proteins and recombinant protein products from plants, plant derived tissues or cultured plant cells |
| 03/13/2002 | EP1185623A1 Genetic and epigenetic manipulation of abc transporters and ecto-phosphatases for the conference of drug resistance and for the loss of drug resistance in biological systems and methods for the detection of ecto-phosphatase inhibitors |
| 03/13/2002 | EP1185620A2 Spheroid preparation |
| 03/13/2002 | EP1185615A2 Recombinant influenza viruses for vaccines and gene therapy |
| 03/13/2002 | EP1185559A2 Compositions and methods for cancer treatment by selectively inhibiting vegf |
| 03/13/2002 | EP1185558A1 Peptide having preptin functionality |
| 03/13/2002 | EP1185557A1 Compositions and methods for the therapy, diagnosis and monitoring of breast cancer |
| 03/13/2002 | EP1185556A1 Use of soluble protein molecules expressed by the pancreas and kidney glomerulus |
| 03/13/2002 | EP1185555A2 Compositions isolated from skin cells and methods for their use |
| 03/13/2002 | EP1185554A1 Peptide having for fibrinogen fragment e activity, analogs, antibodies and uses thereof |
| 03/13/2002 | EP1185552A1 Retro-inverso peptides derived from interleukin-3 |
| 03/13/2002 | EP1185551A1 Method for purification of proteins |
| 03/13/2002 | EP1185549A2 Dna encoding a human subunit of the 5-ht3 serotonin receptor |
| 03/13/2002 | EP1185548A2 Method for drying protein crystals |
| 03/13/2002 | EP1185547A2 Gene expression modulated in gastrointestinal inflammation |
| 03/13/2002 | EP1185545A1 Cd4-independent hiv envelope proteins as vaccines and therapeutics |
| 03/13/2002 | EP1185543A1 50 human secreted proteins |
| 03/13/2002 | EP1185308A2 Glp-1 as a diagnostic test to determine beta-cell function |
| 03/13/2002 | EP1185304A2 Conjugates comprising cytokines and nucleic acids for treating proliferating cells |
| 03/13/2002 | EP1185298A2 Prevention and treatment of amyloidogenic disease |
| 03/13/2002 | EP1185297A2 Streptococcus pneumoniae proteins and vaccines |
| 03/13/2002 | EP1185294A2 Therapeutic methods and compositions for the treatment of impaired interpersonal and behavioral disorders |
| 03/13/2002 | EP1185288A1 Hemoactive compositions and methods for their manufacture and use |
| 03/13/2002 | EP1185286A1 Mu o-conopeptides and their use as local anesthetics |
| 03/13/2002 | EP1185285A1 49 human secreted proteins |
| 03/13/2002 | EP1185284A1 47 human secreted proteins |
| 03/13/2002 | EP1185278A1 Fibrin polymer structure |
| 03/13/2002 | EP1185169A2 USE OF TRANSGENIC MICE LACKING JunB EXPRESSION IN THE MYELOID LINEAGE |
| 03/13/2002 | EP1185158A1 Method for producing stress proteins from vegetable material and harvesting machine for implementing said method |